David Zhao to Coronary Artery Disease
This is a "connection" page, showing publications David Zhao has written about Coronary Artery Disease.
Connection Strength
1.423
-
Leacche M, Byrne JG, Solenkova NS, Reagan B, Mohamed TI, Fredi JL, Zhao DX. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):1004-1012.
Score: 0.334
-
Libby P, Zhao DX. Allograft arteriosclerosis and immune-driven angiogenesis. Circulation. 2003 Mar 11; 107(9):1237-9.
Score: 0.177
-
Paul TK, Bhatheja S, Panchal HB, Zheng S, Banerjee S, Rao SV, Guzman L, Beohar N, Zhao D, Mehran R, Mukherjee D. Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis. Circ Cardiovasc Interv. 2017 Dec; 10(12).
Score: 0.123
-
Panchal HB, Daggubati R, Zhao D, Rao SV, Paul T. Polymer-Free Drug-Coated Coronary Stents in Patients with Stable Coronary Artery Disease at High Bleeding Risk. Curr Cardiol Rep. 2017 02; 19(2):12.
Score: 0.116
-
Puskas JD, Halkos ME, DeRose JJ, Bagiella E, Miller MA, Overbey J, Bonatti J, Srinivas VS, Vesely M, Sutter F, Lynch J, Kirkwood K, Shapiro TA, Boudoulas KD, Crestanello J, Gehrig T, Smith P, Ragosta M, Hoff SJ, Zhao D, Gelijns AC, Szeto WY, Weisz G, Argenziano M, Vassiliades T, Liberman H, Matthai W, Ascheim DD. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study. J Am Coll Cardiol. 2016 07 26; 68(4):356-65.
Score: 0.112
-
Harskamp RE, Bonatti JO, Zhao DX, Puskas JD, de Winter RJ, Alexander JH, Halkos ME. Standardizing definitions for hybrid coronary revascularization. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):556-60.
Score: 0.093
-
Leacche M, Zhao DX, Umakanthan R, Byrne JG. Do hybrid procedures have proven clinical utility and are they the wave of the future? : hybrid procedures have no proven clinical utility and are not the wave of the future. Circulation. 2012 May 22; 125(20):2504-10; discussion 2510.
Score: 0.084
-
Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012 Apr 25; 307(16):1717-26.
Score: 0.083
-
Geisberg CA, Wang G, Safa RN, Smith HM, Anderson B, Peng XY, Veerkamp B, Zhao DX, Blakemore D, Yu C, Sawyer DB. Circulating neuregulin-1ß levels vary according to the angiographic severity of coronary artery disease and ischemia. Coron Artery Dis. 2011 Dec; 22(8):577-82.
Score: 0.081
-
Jaik NP, Umakanthan R, Leacche M, Solenkova N, Balaguer JM, Hoff SJ, Ball SK, Zhao DX, Byrne JG. Current status of hybrid coronary revascularization. Expert Rev Cardiovasc Ther. 2011 Oct; 9(10):1331-7.
Score: 0.080
-
Leacche M, Umakanthan R, Zhao DX, Byrne JG. Surgical update: hybrid procedures, do they have a role? Circ Cardiovasc Interv. 2010 Oct; 3(5):511-8.
Score: 0.075
-
Byrne JG, Leacche M, Vaughan DE, Zhao DX. Hybrid cardiovascular procedures. JACC Cardiovasc Interv. 2008 Oct; 1(5):459-68.
Score: 0.065